Stockscreener 앱 받기
8.35
7.63%
-0.69
시간 외 거래:
8.35
전일 마감가:
$9.04
열려 있는:
$8.7
하루 거래량:
2.99M
Relative Volume:
3.26
시가총액:
$450.91M
수익:
-
순이익/손실:
$-86.60M
주가수익비율:
-2.948
EPS:
-2.8324
순현금흐름:
$-67.37M
1주 성능:
-17.16%
1개월 성능:
+26.13%
6개월 성능:
+79.96%
1년 성능:
+1.33%
1일 변동 폭
$8.14
$9.0399
1주일 범위
$8.14
$10.38
52주 변동 폭
$1.45
$11.72
Lexeo Therapeutics Inc Stock (LXEO) Company Profile
명칭
Lexeo Therapeutics Inc
전화
(212) 547-9879
주소
345 PARK AVENUE SOUTH, NEW YORK
LXEO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LXEO
Lexeo Therapeutics Inc
|
8.35 | 650.61M | 0 | -86.60M | -67.37M | -2.8324 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Lexeo Therapeutics Inc Stock (LXEO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-15 | 개시 | Guggenheim | Buy |
| 2025-07-31 | 개시 | Oppenheimer | Outperform |
| 2024-06-13 | 개시 | Robert W. Baird | Outperform |
| 2024-06-06 | 개시 | H.C. Wainwright | Buy |
| 2023-11-28 | 개시 | Chardan Capital Markets | Buy |
| 2023-11-28 | 개시 | JP Morgan | Overweight |
| 2023-11-28 | 개시 | Leerink Partners | Outperform |
| 2023-11-28 | 개시 | RBC Capital Mkts | Outperform |
| 2023-11-28 | 개시 | Stifel | Buy |
모두보기
Lexeo Therapeutics Inc 주식(LXEO)의 최신 뉴스
Is Lexeo Therapeutics Inc. meeting your algorithmic filter criteriaEarnings Trend Report & Long Hold Capital Preservation Plans - newser.com
Using data models to predict Lexeo Therapeutics Inc. stock movementJuly 2025 Momentum & Low Drawdown Momentum Ideas - newser.com
Using Python tools to backtest Lexeo Therapeutics Inc. strategiesQuarterly Earnings Report & Weekly Watchlist for Hot Stocks - newser.com
What to do if you’re stuck in Lexeo Therapeutics Inc.Market Risk Analysis & Weekly Watchlist of Top Performers - newser.com
Long term hold vs stop loss in Lexeo Therapeutics Inc.Gap Down & AI Driven Stock Reports - newser.com
How Lexeo Therapeutics Inc. stock reacts to bond yieldsEarnings Miss & Smart Allocation Stock Reports - newser.com
Can Lexeo Therapeutics Inc. stock withstand economic slowdown2025 Top Gainers & Verified Short-Term Trading Plans - newser.com
Using Ichimoku Cloud for Lexeo Therapeutics Inc. technicalsPortfolio Value Report & Real-Time Market Trend Scan - newser.com
Multi asset correlation models including Lexeo Therapeutics Inc.July 2025 Levels & Real-Time Chart Breakout Alerts - newser.com
Is Lexeo Therapeutics (LXEO) One of Billionaire Daniel Sundheim’s Stock Picks with Huge Upside Potential - Yahoo! Finance Canada
Will Lexeo Therapeutics Inc. price bounce be sustainableTrade Volume Summary & Verified Technical Trade Signals - newser.com
Using data filters to optimize entry into Lexeo Therapeutics Inc.Portfolio Return Summary & Verified Momentum Stock Ideas - newser.com
Will Lexeo Therapeutics Inc. stock outperform Nasdaq index2025 EndofYear Setup & Safe Capital Allocation Plans - newser.com
Should you hold or exit Lexeo Therapeutics Inc. nowWeekly Volume Report & Risk Managed Investment Strategies - newser.com
Why hedge funds are buying Lexeo Therapeutics Inc. stockEarnings Beat & High Conviction Buy Zone Picks - newser.com
Best data tools to analyze Lexeo Therapeutics Inc. stockGap Down & Weekly Return Optimization Plans - newser.com
Real time pattern detection on Lexeo Therapeutics Inc. stock2025 Growth vs Value & Fast Gain Stock Trading Tips - newser.com
Can Lexeo Therapeutics Inc. stock double in next 5 yearsJuly 2025 Opening Moves & Risk Controlled Swing Trade Alerts - newser.com
RA CAPITAL MANAGEMENT, L.P. Acquires 5 Million Shares in Lexeo T - GuruFocus
RA CAPITAL MANAGEMENT, L.P. Acquires 5 Million Shares in Lexeo Therapeutics Inc - GuruFocus
Risk vs reward if holding onto Lexeo Therapeutics Inc.Market Activity Recap & Real-Time Stock Entry Alerts - newser.com
Lexeo Therapeutics (LXEO) Price Target Increased by 19.77% to 21.29 - Nasdaq
Lexeo Therapeutics Inc (LXEO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Lexeo Therapeutics Inc 주식 (LXEO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Robertson Jenny | Chief Legal Officer |
Oct 17 '25 |
Sale |
8.94 |
3,526 |
31,530 |
68,930 |
| Otero Jose Manuel | Chief Technical Officer |
Oct 17 '25 |
Sale |
8.94 |
2,115 |
18,913 |
64,197 |
| Adler Eric | Chief Medical Officer |
Oct 17 '25 |
Sale |
8.94 |
3,382 |
30,242 |
73,261 |
| Townsend Richard Nolan | Chief Executive Officer |
Oct 17 '25 |
Sale |
8.94 |
13,133 |
117,436 |
242,118 |
1.45%
0.86%
자본화:
|
볼륨(24시간):